Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease

Published:2021-09-23 Issue:11 Volume:29 Page:1950-1960
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Barb Diana¹,Repetto Enrico M.²,Stokes Michael E.³,Shankar Sudha S.⁴,Cusi Kenneth¹⁵^ORCID

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism University of Florida Gainesville Florida USA

2. Global Medicines DevelopmentAstraZeneca plc Gaithersburg Maryland USA

3. Real‐World Evidence Evidera, Waltham Massachusetts USA

4. Early Clinical DevelopmentAstraZeneca plc Gaithersburg Maryland USA

5. Division of Endocrinology, Diabetes and Metabolism Malcom Randall Veterans Affairs Medical Center Gainesville Florida USA

Funder

AstraZeneca

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.23263

Reference46 articles.

1. Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes

2. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?

3. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.

4. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

5. From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating combined effects of chronic, low-dose exposures of cadmium (CLEC) and hyperglycemia on insulin signaling dysfunction in a hepatocellular model;Toxicology;2024-11

2. Smoking, all-cause, and cause-specific mortality in individuals with diabetes in Mexico: an analysis of the Mexico city prospective study;BMC Public Health;2024-09-02

3. Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis;Clinical Gastroenterology and Hepatology;2024-09

4. Liver fibrosis according to diabetes status and relation to cardiovascular risk and mortality in US adults;American Heart Journal Plus: Cardiology Research and Practice;2024-09

5. Beneficial effects of MGL‐3196 and BAM15 combination in a mouse model of fatty liver disease;Acta Physiologica;2024-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3